These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22693346)

  • 21. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
    Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes.
    Ford CD; Gazdik MA; Lopansri BK; Webb B; Mitchell B; Coombs J; Hoda D; Petersen FB
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):340-346. PubMed ID: 27890428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.
    Cheah AL; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    BMC Infect Dis; 2014 Jun; 14():353. PubMed ID: 24973797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
    Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
    Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.
    Butler AM; Olsen MA; Merz LR; Guth RM; Woeltje KF; Camins BC; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):28-35. PubMed ID: 19951200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients.
    Zirakzadeh A; Gastineau DA; Mandrekar JN; Burke JP; Johnston PB; Patel R
    Bone Marrow Transplant; 2008 Feb; 41(4):385-92. PubMed ID: 18084341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
    Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
    Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.
    Lautenbach E; Bilker WB; Brennan PJ
    Infect Control Hosp Epidemiol; 1999 May; 20(5):318-23. PubMed ID: 10349947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
    Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI
    Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
    Salgado CD
    Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
    Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
    BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kamboj M; Cohen N; Huang YT; Kerpelev M; Jakubowski A; Sepkowitz KA; Papanicolaou GA; Seo SK
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):594-598. PubMed ID: 30448456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
    Olivier CN; Blake RK; Steed LL; Salgado CD
    Infect Control Hosp Epidemiol; 2008 May; 29(5):404-9. PubMed ID: 18419361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
    Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
    Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
    Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
    Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.
    Kamboj M; Chung D; Seo SK; Pamer EG; Sepkowitz KA; Jakubowski AA; Papanicolaou G
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1576-81. PubMed ID: 20685257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria.
    Khair HN; VanTassell P; Henderson JP; Warren DK; Marschall J;
    J Hosp Infect; 2013 Nov; 85(3):183-8. PubMed ID: 23998947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin-resistant enterococci infection: not just for the transplanted.
    Rosko AE; Corriveau M; Suwantarat N; Arfons L; Treasure M; Parker P; Jacobs M; Fu P; Salata R; Lazarus HM
    Leuk Lymphoma; 2014 Jun; 55(6):1320-5. PubMed ID: 24024476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
    Zaas AK; Song X; Tucker P; Perl TM
    Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.